所有图片(1)
About This Item
经验公式（希尔记法）:
C16H14F3N3O2S
CAS号:
分子量:
369.36
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24
推荐产品
等級
pharmaceutical primary standard
API 家族
lansoprazole
製造商／商標名
USP
應用
pharmaceutical (small molecule)
格式
neat
SMILES 字串
Cc1c(CS(=O)c2nc3ccccc3[nH]2)nccc1OCC(F)(F)F
InChI
1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)
InChI 密鑰
MJIHNNLFOKEZEW-UHFFFAOYSA-N
基因資訊
human ... ATP4A(495) , ATP4B(496)
正在寻找类似产品? 访问 产品对比指南
一般說明
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
應用
Lansoprazole USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
- Lansoprazole Compounded Oral Suspension
- Lansoprazole Delayed-Release Capsules
分析報告
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他說明
Sales restrictions may apply.
相關產品
产品编号
说明
价格
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 2
閃點（°F）
Not applicable
閃點（°C）
Not applicable
其他客户在看
A modified high-performance liquid chromatographic method for the analysis of pantoprazole sodium in pharmaceutical dosage forms using lansoprazole as internal standard.
Ashour, Safwan, and Soulafa Omar.
Arabian Journal of Chemistry, 1-6 (2011)
T Iwahi et al.
Antimicrobial agents and chemotherapy, 35(3), 490-496 (1991-03-01)
The activities of various types of antiulcer agents against Helicobacter pylori (formerly called Campylobacter pylori) strains were determined by an agar dilution method. Among the compounds tested, two benzimidazole proton pump inhibitors, lansoprazole (AG-1749) and omeprazole, were found to have
Hiroto Miwa et al.
Journal of gastroenterology and hepatology, 30(5), 834-841 (2015-01-07)
Non-erosive reflux disease (NERD) and functional dyspepsia (FD) share some common features, and the appropriateness of managing these diseases independently has been questioned. A post-hoc subgroup analysis of the LEGEND study was performed to compare demographics and treatment response between
Ken Haruma et al.
Internal medicine (Tokyo, Japan), 54(7), 695-701 (2015-04-04)
Although gastroesophageal reflux disease (GERD), a very common disorder worldwide, is considered to be a lifestyle disease, the pathogenic role of lifestyle factors and consequently the efficacy of lifestyle interventions, remains controversial. Lifestyle factors associated with GERD and the beneficial
Yasunobu Yamashita et al.
PloS one, 9(5), e97419-e97419 (2014-05-23)
Lansoprazole is a potent anti-gastric ulcer drug that inhibits gastric proton pump activity. We identified a novel function for lansoprazole, as an inducer of anti-oxidative stress responses in the liver. Gastric administration of lansoprazole (10-100 mg/kg) to male Wistar rats
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门